Wave Life Sciences (WVE) risk factors

Item 1A of every Wave Life Sciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open WVE in Gloom →

Wave Life Sciences' chart, financials and news, free in your browser.Open WVE in Gloom →

FY2025 10-K risk factors
75 risks6 new8 dropped15 reworded
Wave Life Sciences added risks covering clinical stage uncertainties, outpatient Medicare reimbursement, reliance on commercial partners, and expanding global data privacy rules.
Filed Feb 26, 2026
FY2024 10-K risk factors
77 risks
Clinical-stage biotechnology company developing RNA medicines via the PRISM platform with recurring operating losses. Extensive reliance on external funding, third-party collaborations, and complex oligonucleotide manufacturing.
Filed Mar 04, 2025